SUBSCRIBE
SUBSCRIBE
News   Policy

US FDA Warns Eli Lilly and Company, Sanofi-Aventis (France), Meda AB on Misleading Promotions

February 4, 2010 | 
1 min read
Reuters -- U.S. health officials have warned Sanofi Aventis SA, Eli Lilly & Co and Meda AB about misleading promotions for prescription drugs, letters released on Wednesday said.
Legal Regulatory
Eli Lilly and Company Food and Drug Administration (FDA) Sanofi (France)
MORE ON THIS TOPIC
Podcast
Pfizer Wins Metsera, Trump Strikes GLP-1 Pricing Deal, FDA Awards More Priority Vouchers
November 12, 2025
 · 
1 min read
 · 
Heather McKenzie
Silver Spring, MD, USA 11/10/2020: Exterior view of the headquarters of US Food and Drug Administration (FDA). This federal agency approves medications, vaccines and food additives for human use.
FDA
FDA Stalwart Pazdur Named Tidmarsh’s Replacement as CDER Director
November 11, 2025
 · 
1 min read
 · 
Heather McKenzie
factory of the pharmaceutical industry. pills on the conveyor
Manufacturing
Drugmakers Push FDA To Extend Support to Existing Facilities
November 11, 2025
 · 
4 min read
 · 
Nick Paul Taylor
FDA
FDA Removes Black Box Warning From HRT Products, Reversing Landmark Decision
November 10, 2025
 · 
2 min read
 · 
Heather McKenzie